Eikon Therapeutics Alternatives & Competitors
12 companies similar to Eikon Therapeutics — Eikon is a late-stage clinical biopharmaceutical company dedicated to inventing...
Companies similar to Eikon Therapeutics
Relay Therapeutics
Integrating leading-edge computational and experimental science to transform human health....
Cambridge, United States
Celsius Therapeutics
On a quest to leverage the power of single cell genomics to discover novel drug targets an...
Cambridge, United States
Synnovation Therapeutics
A precision oncology company focused on small molecule therapies optimized to target key d...
Wilmington, United States
Avelos Therapeutics
Strive for a Better Tomorrow.
Seoul, Korea South
Rival Readout
Competing with Eikon Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
IDEAYA Biosciences
Synthetic lethality precision medicine oncology company pursuing– an emerging class of pre...
South San Francisco, Unit...
Degron Therapeutics
Aims to become a global leader in the discovery and development of molecular glue degrader...
San Diego, United States
Nimbus Therapeutics
We develop breakthrough medicines for patients through precision small molecule design.
Boston, United States
Integrated Biosciences, Inc.
Unravelling complex biology with optogenetics, chemistry and computation for small molecul...
Redwood City, United Stat...
Rgenta Therapeutics Inc.
We unlock the therapeutic potentials of highly disease-relevant targets undruggable by sma...
Woburn, United States
Celeris Therapeutics
The PIC Engineering Company.
Menlo Park, United States
Biotheryx, Inc.
Degrading proteins. Saving lives. Building the leader in next-generation targeted protein...
San Diego, United States
About Eikon Therapeutics
Eikon Therapeutics, founded in 2019, is a United States-based late-stage clinical biopharmaceutical company with a focus on inventing and developing breakthrough therapeutics. The company is advancing therapies for patients with unmet medical needs and employs cutting-edge technology such as single-molecule imaging and...
Therapeutics Development, Pipeline Advancement, Novel Target Identification, Data Analysis with Machine Learning
Patients with Unmet Medical Needs, Healthcare Providers, Research Institutions
Biopharmaceutical, Clinical-stage, Therapeutics, Oncology, Immune Response Modulation, Synthetic Lethality, Single-molecule Imaging, Neurological Diseases, Machine Learning Algorithms, Imaging Data Analysis, Drug Discovery, Interdisciplinary Scientific Exploration, Molecular-resolution Imaging, Protein Movement Analysis, Innovative Therapeutic Development
B2B, B2B2C
Product Sales, Licensing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Eikon Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Eikon Therapeutics on 9 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
